Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy

Gilead Sciences Revenue 2006-2018 | GILD

Current and historical revenue for Gilead Sciences (GILD) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Gilead Sciences as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $26.107B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.635B 15.19
Biogen (BIIB) United States $73.532B 15.38
Celgene (CELG) United States $62.110B 12.35
Vertex Pharmaceuticals (VRTX) United States $45.997B 150.42
Illumina (ILMN) United States $45.128B 63.69
Regeneron Pharmaceuticals (REGN) United States $39.593B 23.51
Alexion Pharmaceuticals (ALXN) United States $30.231B 25.16
BioMarin Pharmaceutical (BMRN) United States $18.309B 0.00
Incyte (INCY) United States $14.878B 0.00
Seattle Genetics (SGEN) United States $11.147B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.803B 0.00
Sarepta Therapeutics (SRPT) United States $9.136B 0.00
Bluebird Bio (BLUE) United States $9.051B 0.00
BeiGene (BGNE) Cayman Islands $8.930B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.467B 28.32
Exact Sciences (EXAS) United States $7.772B 0.00
Alkermes (ALKS) Ireland $6.864B 0.00
Exelixis (EXEL) United States $6.489B 26.34
Bio-Techne Corp (TECH) United States $5.753B 39.46
Integra LifeSciences Holdings (IART) United States $5.536B 29.72
Galapagos (GLPG) Belgium $5.131B 0.00
Ligand Pharmaceuticals (LGND) United States $4.709B 63.17
Immunomedics (IMMU) United States $4.281B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.209B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.962B 0.00
Array BioPharma (ARRY) United States $3.596B 0.00
China Biologic Products (CBPO) China $3.343B 22.08
Spark Therapeutics (ONCE) United States $3.177B 0.00
CRISPR THERAPTC (CRSP) Switzerland $3.101B 0.00
Myriad Genetics (MYGN) United States $2.984B 36.18
Amicus Therapeutics (FOLD) United States $2.968B 0.00
Medicines (MDCO) United States $2.947B 0.00
Blueprint Medicines (BPMC) United States $2.936B 0.00
Ascendis Pharma (ASND) Denmark $2.895B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.873B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.861B 0.00
Horizon Pharma Public (HZNP) Ireland $2.789B 17.07
Emergent Biosolutions (EBS) United States $2.738B 35.01
Clovis Oncology (CLVS) United States $2.550B 0.00
Halozyme Therapeutics (HALO) United States $2.486B 38.38
REGENXBIO (RGNX) United States $2.470B 57.30
Akcea Therapeutics (AKCA) United States $2.379B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.179B 0.00
Arena Pharmaceuticals (ARNA) United States $2.175B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.172B 0.00
Global Blood Therapeutics (GBT) United States $2.107B 0.00
Acceleron Pharma (XLRN) United States $2.099B 0.00
Repligen (RGEN) United States $2.091B 66.47
Puma Biotechnology (PBYI) United States $2.031B 0.00
MyoKardia (MYOK) United States $2.002B 0.00
Insmed (INSM) United States $1.942B 0.00
Genomic Health (GHDX) United States $1.874B 331.00
Cambrex (CBM) United States $1.818B 16.71
Editas Medicine (EDIT) United States $1.792B 0.00
Atara Biotherapeutics (ATRA) United States $1.756B 0.00
Aimmune Therapeutics (AIMT) United States $1.702B 0.00
AnaptysBio (ANAB) United States $1.680B 0.00
IMMURON LTD (IMRN) Australia $1.628B 0.00
BIOHAVEN PHARM (BHVN) United States $1.625B 0.00
Sangamo Therapeutics (SGMO) United States $1.528B 0.00
Innoviva (INVA) United States $1.518B 11.13
Solid Biosciences (SLDB) United States $1.502B 0.00
UniQure (QURE) Netherlands $1.462B 0.00
Mirati Therapeutics (MRTX) United States $1.431B 0.00
G1 THERAPEUTICS (GTHX) United States $1.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.410B 0.00
Intellia Therapeutics (NTLA) United States $1.405B 0.00
Acorda Therapeutics (ACOR) United States $1.403B 0.00
Audentes Therapeutics (BOLD) United States $1.400B 0.00
Denali Therapeutics (DNLI) United States $1.368B 0.00
Myovant Sciences (MYOV) United Kingdom $1.362B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.306B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.305B 0.00
Lion Biotechnologies (IOVA) United States $1.237B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.190B 0.00
Cellectis (CLLS) France $1.180B 0.00
Athenex (ATNX) United States $1.176B 0.00
Retrophin (RTRX) United States $1.144B 0.00
NeoGenomics (NEO) United States $1.120B 231.50
Intra-Cellular Therapies (ITCI) United States $1.118B 0.00
DBV Technologies (DBVT) France $1.109B 0.00
Reata Pharmaceuticals (RETA) United States $1.104B 0.00
Revance Therapeutics (RVNC) United States $1.087B 0.00
WAVE Life Sciences (WVE) Singapore $1.081B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.068B 0.00
Apellis Pharmaceuticals (APLS) United States $1.060B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.032B 0.00
Dynavax Technologies (DVAX) United States $0.940B 0.00
Coherus BioSciences (CHRS) United States $0.930B 0.00
Epizyme (EPZM) United States $0.924B 0.00
CytomX Therapeutics (CTMX) United States $0.896B 0.00
Amarin (AMRN) Ireland $0.892B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.889B 0.00
ANI Pharmaceuticals (ANIP) United States $0.836B 17.12
Sorrento Therapeutics (SRNE) United States $0.820B 0.00
Heska (HSKA) United States $0.809B 61.99
AUTOLUS THERAPT (AUTL) United Kingdom $0.809B 0.00
InflaRx (IFRX) Germany $0.792B 0.00
AC Immune SA (ACIU) Switzerland $0.790B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.782B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.774B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.764B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.747B 0.00
EIDOS THERAPEUT (EIDX) United States $0.744B 0.00
Cara Therapeutics (CARA) United States $0.710B 0.00
Abeona Therapeutics (ABEO) United States $0.698B 0.00
APTINYX INC (APTX) United States $0.686B 0.00
Kura Oncology (KURA) United States $0.664B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.660B 0.00
UROGEN PHARMA (URGN) Israel $0.656B 0.00
Viking Therapeutics (VKTX) United States $0.651B 0.00
AVROBIO INC (AVRO) United States $0.650B 0.00
Arbutus Biopharma (ABUS) Canada $0.645B 0.00
UNITY Biotechnology (UBX) $0.641B 0.00
Senesco Technologies (ELOX) United States $0.630B 0.00
Fate Therapeutics (FATE) United States $0.627B 0.00
Geron (GERN) United States $0.627B 0.00
Monster Digital (INNT) United States $0.609B 0.00
Five Prime Therapeutics (FPRX) United States $0.608B 0.00
ObsEva SA (OBSV) Switzerland $0.595B 0.00
Prothena (PRTA) Ireland $0.595B 0.00
BeyondSpring (BYSI) United States $0.583B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.577B 0.00
Merus (MRUS) Netherlands $0.573B 0.00
Mesoblast (MESO) Australia $0.544B 0.00
Arcus Biosciences (RCUS) United States $0.543B 0.00
Aduro Biotech (ADRO) United States $0.539B 0.00
Tigenix (TIG) Belgium $0.534B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.529B 0.00
Anika Therapeutics (ANIK) United States $0.521B 20.65
Novavax (NVAX) United States $0.519B 0.00
Cytokineticsorporated (CYTK) United States $0.504B 0.00
Stemline Therapeutics (STML) United States $0.490B 0.00
Verastem (VSTM) United States $0.487B 0.00
Unum Therapeutics (UMRX) United States $0.482B 0.00
Zymeworks (ZYME) Canada $0.477B 0.00
Zealand Pharma (ZEAL) Denmark $0.466B 0.00
MAGENTA THERAPT (MGTA) United States $0.459B 0.00
Sinovac Biotech (SVA) China $0.450B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.444B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.434B 0.00
Evelo Biosciences (EVLO) United States $0.416B 0.00
Albireo Pharma (ALBO) United States $0.411B 0.00
Syros Pharmaceuticals (SYRS) United States $0.401B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.398B 0.00
PDL BioPharma (PDLI) United States $0.390B 3.98
Inovio Pharmaceuticals (INO) United States $0.388B 0.00
Scholar Rock Holding (SRRK) United States $0.386B 0.00
MiMedx (MDXG) United States $0.374B 16.05
Mersana Therapeutics (MRSN) United States $0.373B 0.00
MediciNova (MNOV) United States $0.362B 0.00
RA PHARMCTL INC (RARX) United States $0.361B 0.00
Seres Therapeutics (MCRB) United States $0.356B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.350B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.345B 0.00
Cellular Biomedicine (CBMG) United States $0.340B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.337B 0.00
GTx (GTXI) United States $0.336B 0.00
Kindred Biosciences (KIN) United States $0.334B 0.00
Vericel (VCEL) United States $0.334B 0.00
Clearside Biomedical (CLSD) United States $0.328B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.323B 0.00
Adverum Biotechnologies (ADVM) United States $0.321B 0.00
Vital Therapies (VTL) United States $0.318B 0.00
Kala Pharmaceuticals (KALA) United States $0.311B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.302B 0.00
Selecta Biosciences (SELB) United States $0.298B 0.00
BioTime (BTX) United States $0.296B 0.00
Synlogic (SYBX) United States $0.293B 0.00
KEZAR LIFE SCI (KZR) United States $0.289B 0.00
Axovant Sciences (AXON) United Kingdom $0.288B 0.00
MEIRAGTX HLDGS (MGTX) United States $0.286B 0.00
Athersys (ATHX) United States $0.284B 0.00
Celyad SA (CYAD) Belgium $0.283B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.283B 0.00
OVID THERAPEUTC (OVID) United States $0.271B 0.00
Kadmon Holdings (KDMN) United States $0.260B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.258B 0.00
ResTORbio (TORC) United States $0.257B 0.00
Strongbridge Biopharma (SBBP) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.245B 0.00
NantKwest (NK) United States $0.243B 0.00
Cohbar (CWBR) United States $0.242B 0.00
Enzo Biochem (ENZ) United States $0.241B 0.00
Cue Biopharma (CUE) United States $0.238B 0.00
MannKind (MNKD) United States $0.238B 0.00
Allena Pharmaceuticals (ALNA) United States $0.236B 0.00
Celcuity (CELC) United States $0.229B 0.00
Agenus (AGEN) United States $0.228B 0.00
Kamada (KMDA) Israel $0.225B 18.06
ProQR Therapeutics (PRQR) Netherlands $0.225B 0.00
Signal Genetics (MGEN) United States $0.222B 0.00
Idera Pharmaceuticals (IDRA) United States $0.219B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
Mustang Bio (MBIO) United States $0.203B 0.00
Palatin Technologies (PTN) United States $0.203B 7.85
Erytech Pharma SA Sponsored ADR (ERYP) $0.197B 0.00
XOMA (XOMA) United States $0.194B 14.72
Nymox Pharmaceutical (NYMX) Canada $0.193B 0.00
Menlo Therapeutics (MNLO) United States $0.193B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.192B 0.00
TOCAGEN INC (TOCA) United States $0.190B 0.00
VBI Vaccines (VBIV) United States $0.188B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.183B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.181B 0.00
NewLink Genetics (NLNK) United States $0.180B 0.00
Krystal Biotech (KRYS) United States $0.177B 0.00
Spero Therapeutics (SPRO) United States $0.174B 0.00
BioDelivery Sciences (BDSI) United States $0.172B 0.00
BioXcel Therapeutics (BTAI) United States $0.171B 0.00
Compugen (CGEN) Israel $0.169B 0.00
Bellerophon Therapeutics (BLPH) United States $0.166B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.166B 0.00
Fortress Biotech (FBIO) United States $0.160B 0.00
Protagonist Therapeutics (PTGX) United States $0.158B 0.00
XBiotech (XBIT) United States $0.152B 0.00
Intec Pharma (NTEC) Israel $0.151B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.150B 0.00
Organovo Holdings (ONVO) United States $0.149B 0.00
Catalyst Biosciences (CBIO) United States $0.148B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.145B 0.00
Pluristem Therapeutics (PSTI) Israel $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.143B 0.00
Cidara Therapeutics (CDTX) United States $0.138B 0.00
Motif Bio Plc (MTFB) United States $0.134B 0.00
Cocrystal Pharma (COCP) United States $0.131B 0.00
Cerecor (CERC) United States $0.130B 20.65
Pfenex (PFNX) United States $0.126B 0.00
Leap Therapeutics (LPTX) United States $0.124B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.121B 0.00
PSivida (EYPT) United States $0.116B 0.00
Gemphire Therapeutics (GEMP) United States $0.114B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.113B 0.00
Aptevo Therapeutics (APVO) United States $0.112B 0.00
Tapimmune (TPIV) United States $0.111B 0.00
Trevena (TRVN) United States $0.109B 0.00
Aptose Biosciences (APTO) Canada $0.107B 0.00
Proteostasis Therapeutics (PTI) United States $0.103B 0.00
ScPharmaceuticals (SCPH) United States $0.102B 0.00
GENPREX INC (GNPX) United States $0.101B 0.00
Asterias Biotherapeutics (AST) United States $0.099B 0.00
Ophthotech (OPHT) United States $0.098B 0.67
Eleven Biotherapeutics (SESN) United States $0.097B 0.00
Sophiris Bio (SPHS) United States $0.095B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.094B 0.00
Alcobra (ARCT) Israel $0.094B 0.00
Orgenesis (ORGS) United States $0.091B 0.00
Oncolytics Biotech (ONCY) Canada $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.086B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.084B 0.00
VIVUS (VVUS) United States $0.082B 0.00
Axsome Therapeutics (AXSM) United States $0.081B 0.00
ENTERA BIO LTD (ENTX) Israel $0.076B 0.00
Celldex Therapeutics (CLDX) United States $0.075B 0.00
Aileron Therapeutics (ALRN) United States $0.074B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Applied Genetic Technologies (AGTC) United States $0.072B 0.00
Histogenics (HSGX) United States $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.071B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Novelion Therapeutics (NVLN) Canada $0.069B 0.00
Neothetics (EVFM) United States $0.068B 0.00
OncoSec Medical (ONCS) United States $0.068B 0.00
Protalix BioTherapeutics (PLX) Israel $0.065B 0.00
Vascular Biogenics (VBLT) Israel $0.064B 0.00
Eyenovia (EYEN) United States $0.064B 0.00
Curis (CRIS) United States $0.063B 0.00
VolitionRX (VNRX) Singapore $0.061B 0.00
Caladrius Biosciences (CLBS) United States $0.059B 0.00
Celsion (CLSN) United States $0.054B 0.00
Zosano Pharma (ZSAN) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.049B 0.00
Arsanis (ASNS) United States $0.049B 0.00
Proteon Therapeutics (PRTO) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.047B 0.00
Moleculin Biotech (MBRX) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.043B 0.00
CytRx (CYTR) United States $0.042B 0.00
BioPharmX (BPMX) United States $0.041B 0.00
Cellect Biotechnology (APOP) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Chiasma (CHMA) United States $0.038B 0.00
Benitec Biopharma (BNTC) Australia $0.035B 0.00
OvaScience (OVAS) United States $0.034B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
Edge Therapeutics (EDGE) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Oncobiologics (ONS) United States $0.029B 0.00
ATyr Pharma (LIFE) United States $0.028B 0.00
Synthetic Biologics (SYN) United States $0.028B 0.00
Vical (VICL) United States $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.025B 0.00
RestorGenex (DFFN) United States $0.023B 0.00
CorMedix Inc (CRMD) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Cel-Sci (CVM) United States $0.020B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Neuralstem (CUR) United States $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Flex Pharma (FLKS) United States $0.015B 0.00
Cerulean Pharma (DARE) United States $0.015B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Fibrocell Science Inc (FCSC) United States $0.014B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.011B 5.47
Galena Biopharma (SLS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
IBio (IBIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.007B 0.00
Immune Pharmaceuticals (IMNP) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.005B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00